|MPLA-SM||Unit size||Cat. code||Docs||Qty||Price|
Monophosphoryl Lipid A from S. minnesota R595
Monophosphoryl Lipid A from Salmonella minnesota R595
Monophosphoryl Lipid A (MPLA-SM) is extracted from lipopolysaccharide (LPS or endotoxin) produced by the Re mutant of a rough strain Salmonella minnesota R595.
Species: Salmonella enterica serovar minnesota mutant R595
Specificity: TLR4 agonist
Working concentration: 10 ng - 1 μg/ml
Endotoxin level: > 0.5 x 106 EU/mg
Appearance: Clear lipidic film
Solubility: 1 mg/ml in DMSOBack to the top
MPLA-SM is provided as a clear, lyophilized lipidic film.
- 1 mg Monophosphoryl Lipid A (MPLA-SM)
MPLA-SM is shipped at room temperature.
Store at -20°C. Upon resuspension, prepare aliquots of MPLA and store at -20°C.
Product is stable 6 months at -20°C.
Avoid repeated freeze-thaw cycles.Back to the top
MPLA-SM is a potent activator of TLR4 with negligible TLR2 activity. MPLA-SM was extracted from LPS using treatment with acid and heat followed by chromatography. Preparations of natural MPLA, such as MPLA-SM, contain a mixture of 5, 6, and 7 acyl lipid A .
Note: Due to the intrinsic structural complexity of lipid A, some batch-to-batch variation may occur.
1. Qureshi n. et al., 1985. Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination. J. Biol. Chem. 260, 5271–8.Back to the top